|
1
|
Le L, Chi K, Tyldesley S, et al:
Identification of serum amyloid A as a biomarker to distinguish
prostate cancer patients with bone lesions. Clin Chem. 51:695–707.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Yu Y, Chen S, Wang LS, et al: Prediction
of pancreatic cancer by serum biomarkers using surface-enhanced
laser desorption/ionization-based decision tree classification.
Oncology. 68:79–86. 2005. View Article : Google Scholar
|
|
3
|
Traub F, Feist H, Kreipe HH and Pich A:
SELDI-MS-based expression profiling of ductal invasive and lobular
invasive human breast carcinomas. Pathol Res Pract. 201:763–770.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Cho WC and Ngan RK: Biomarker discovery in
nasopharyngeal carcinoma using proteinchip profiling. J Hong Kong
Coll Radiol. 11:63–68. 2008.
|
|
5
|
Cho WC: Proteomics technologies and
challenges. Genomics Proteomics Bioinformatics. 5:77–85. 2007.
View Article : Google Scholar
|
|
6
|
Sasazuki S, Inoue M, Sawada N, et al:
Plasma levels of C-reactive protein and serum amyloid A and gastric
cancer in a nested case-control study: Japan Public Health
Center-based prospective study. Carcinogenesis. 31:712–718. 2010.
View Article : Google Scholar
|
|
7
|
Chan DC, Chen CJ, Chu HC, et al:
Evaluation of serum amyloid A as a biomarker for gastric cancer.
Ann Surg Oncol. 14:84–93. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Cho WC: Research progress in SELDI-TOF-MS
and its clinical applications. Sheng Wu Gong Cheng Xue Bao.
22:871–876. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Woong-Shick A, Sung-Pil P, Su-Mi B, et al:
Identification of hemoglobin-alpha and -beta subunits as potential
serum biomarkers for the diagnosis and prognosis of ovarian cancer.
Cancer Sci. 96:197–201. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Liang Y, Fang M, Li J, et al: Serum
proteomic patterns for gastric lesions as revealed by SELDI mass
spectrometry. Exp Mol Pathol. 81:176–180. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Valle RP, Chavany C, Zhukov TA and
Jendoubi M: New approaches for biomarker discovery in lung cancer.
Expert Rev Mol Diagn. 3:55–67. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yokoi K, Shih LC, Kobayashi R, et al:
Serum amyloid A as a tumor marker in sera of nude mice with
orthotopic human pancreatic cancer and in plasma of patients with
pancreatic cancer. Int J Oncol. 27:1361–1369. 2005.PubMed/NCBI
|
|
13
|
Laronga C, Becker S, Watson P, et al:
SELDI-TOF serum profiling for prognostic and diagnostic
classification of breast cancers. Dis Markers. 19:229–238. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Adam BL, Qu Y, Davis JW, et al: Serum
protein fingerprinting coupled with a pattern-matching algorithm
distinguishes prostate cancer from benign prostate hyperplasia and
healthy men. Cancer Res. 62:3609–3614. 2002.
|
|
15
|
Petricoin EF, Ardekani AM, Hitt BA, et al:
Use of proteomic patterns in serum to identify ovarian cancer.
Lancet. 359:572–577. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Cui JF, Liu YK, Zhou HJ, et al: Screening
serum hepatocellular carcinoma-associated proteins by SELDI-based
protein spectrum analysis. World J Gastroenterol. 14:1257–1262.
2008. View Article : Google Scholar
|
|
17
|
Ge Z, Zhu YL, Zhong X, Yu JK and Zheng S:
Discovering differential protein expression caused by CagA-induced
ERK pathway activation in AGS cells using the SELDI-ProteinChip
platform. World J Gastroenterol. 14:554–562. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Cho WC, Yip TT, Ngan RK, et al:
ProteinChip array profiling for identification of disease- and
chemotherapy-associated biomarkers of nasopharyngeal carcinoma.
Clin Chem. 53:241–250. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Malle E and De Beer FC: Human serum
amyloid A (SAA) protein: a prominent acute-phase reactant for
clinical practice. Eur J Clin Invest. 26:427–435. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kokubun M, Imafuku Y, Okada M, Ohguchi Y,
Ashikawa T, Yamada T and Yoshida H: Serum amyloid A (SAA)
concentration varies among rheumatoid arthritis patients estimated
by SAA/CRP ratio. Clin Chim Acta. 360:92–102. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Weinstein PS, Skinner M, Sipe JD, Lokich
JJ, Zamcheck N and Cohen AS: Acute-phase proteins or tumour
markers: the role of SAA, SAP, CRP and CEA as indicators of
metastasis in a broad spectrum of neoplastic diseases. Scand J
Immunol. 19:193–198. 1984. View Article : Google Scholar : PubMed/NCBI
|
